Discounted Cash Flow Rating

Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Sell

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Vir Biotechnology, Inc. Common Stock (VIR)

Biological Products, (no Disgnostic Substances)

https://www.vir.bio

Vir Biotechnology Inc is a commercial-stage immunology company focused on treating and preventing infectious diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

1800 OWENS STREET, SUITE 900
SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/11/2019

Market Cap

1,173,737,600

Shares Outstanding

134,520,000

Weighted SO

134,521,285

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

CVAC --.--%

RETA --.--%

KRYS --.--%

PPCB --.--%

ISEE --.--%

BPMC --.--%

AMLX --.--%

KRTX --.--%

DAWN --.--%

Beta

0.4760

Last Div

0.0000

Range

7.61-13.27

Chg

-0.0700

Avg Vol

1138741

Mkt Cap

1173737600

Exch

NASDAQ

Country

US

Phone

415 906 4324

DCF Diff

11.3212

DCF

-0.0812

Div Yield

0.0000

P/S

16.2703

EV Multiple

-2.0809

P/FV

0.8163

Div Yield %

0.0000

P/E

-2.4227

PEG

0.0111

Payout

0.0000

Current Ratio

12.5061

Quick Ratio

12.5061

Cash Ratio

3.2238

DSO

36.4292

DIO

0.0000

Op Cycle

36.4292

DPO

112.7920

CCC

-76.3628

Gross Margin

0.8031

Op Margin

-6.7327

Pretax Margin

-6.8239

Net Margin

-6.6959

Eff Tax Rate

0.0188

ROA

-0.2893

ROE

-0.3093

ROCE

-0.3087

NI/EBT

0.9812

EBT/EBIT

1.0135

EBIT/Rev

-6.7327

Debt Ratio

0.0686

D/E

0.0799

LT Debt/Cap

0.0622

Total Debt/Cap

0.0740

Int Coverage

-2032.1925

CF/Debt

-3.9384

Equity Multi

1.1645

Rec Turnover

10.0194

Pay Turnover

3.2360

Inv Turnover

999999.9999

FA Turnover

0.5621

Asset Turnover

0.0432

OCF/Share

-3.3104

FCF/Share

-3.3676

Cash/Share

8.5516

OCF/Sales

-6.2516

FCF/OCF

1.0173

CF Coverage

-3.9384

ST Coverage

-23.1338

CapEx Coverage

-57.9161

Div&CapEx Cov

-57.9161

P/BV

0.8163

P/B

0.8163

P/S

16.2703

P/E

-2.4227

P/FCF

-2.5584

P/OCF

-2.5948

P/CF

-2.5948

PEG

0.0111

P/S

16.2703

EV Multiple

-2.0809

P/FV

0.8163

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jun 26, 05:00 TGS Webcast Details for Q2 2025 Presentation GlobeNewswire Inc. Jun 13, 20:47 Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); Manhattan Associates, Inc. (NASDAQ: MANH); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NASDAQ: VIRT) GlobeNewswire Inc. Jun 03, 05:30 Viridien établit une nouvelle référence dans l’acquisition de données sismiques avec le lancement d’Accel de Sercel - la première solution de « drop node » terrestre au monde GlobeNewswire Inc. Jun 03, 05:30 Viridien sets new seismic data acquisition standard with launch of Sercel Accel – the world’s first onshore drop node solution GlobeNewswire Inc. Mar 21, 21:54 Atea Pharmaceuticals Issues Statement Regarding Director Nominations Benzinga Dec 27, 20:44 Deal Dispatch: Party City Wraps Up, Big Lots Goes Bust, The Container Store Continues GlobeNewswire Inc. Dec 14, 01:30 KBW Announces Index Rebalancing for Fourth-Quarter 2024 GlobeNewswire Inc. Sep 09, 05:23 The 24th China International Fair for Investment & Trade opened in Xiamen, Fujian Province GlobeNewswire Inc. Jun 13, 05:30 Viridien conclut la vente d’un système de surveillance et d’alerte des navires, Marlin, auprès d’ExxonMobil Guyana Ltd GlobeNewswire Inc. Jun 13, 05:30 Viridien makes sale of Sercel Marlin vessel monitoring and alert system to ExxonMobil Guyana Ltd GlobeNewswire Inc. Jun 12, 05:30 Viridien awarded large seismic imaging project in Algeria by Groupement Berkine   GlobeNewswire Inc. Jun 12, 05:30 Viridien attributaire d’un important contrat d'imagerie sismique en Algérie GlobeNewswire Inc. Jun 11, 06:00 Viridien signe un accord avec Ranch Computing pour dynamiser le paysage des médias numériques GlobeNewswire Inc. Jun 11, 06:00 Viridien Joins Forces with Ranch Computing to Supercharge the Digital Media Landscape GlobeNewswire Inc. Jun 11, 05:30 Viridien wins 20 MUSD contract to supply a Sercel GPR300 OBN solution for North Sea project GlobeNewswire Inc. Jun 11, 05:30 Viridien remporte un contrat de 20 m$ pour la fourniture d'une solution OBN GPR300 Sercel en mer du Nord GlobeNewswire Inc. Jun 10, 05:30 Viridien launches new brand to accelerate growth as an advanced technology company GlobeNewswire Inc. Jun 10, 05:30 Viridien, leader dans les technologies de pointe, lance sa nouvelle marque et accélère sa croissance GlobeNewswire Inc. May 20, 00:53 Virios Therapeutics Announces Pricing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study GlobeNewswire Inc. Feb 29, 14:15 Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results

Revenue Product Segmentation